1. Introduction {#s0005}
===============

Enterovirus 71 (EV71), a common pathogenic agent of hand-foot-and-mouth disease (HFMD), can cause severe complications including herpangina, aseptic meningitis, encephalitis, cardiorespiratory failure, poliomyelitis-like syndrome or even fatal disease ([@bib6], [@bib26]). EV71 predominantly affects children under 5 years old, and causes severe diseases with high morbidity and mortality ([@bib35]). Since it was first isolated in 1969, EV71 outbreaks have occurred frequently in western Pacific region countries, including China ([@bib19], [@bib33]), Japan ([@bib13]), Malaysia ([@bib6]), and Singapore ([@bib37]). The World Health Organization has estimated the occurrence of one million new HFMD cases in China alone between 2011 and 2014 ([@bib41]). To date, no effective vaccines and antiviral drugs have been available to prevent or treat EV71 infection ([@bib43], [@bib45]). Therefore, it is necessary to identify the host factors involved in the replication of EV71 to control the development and complications of HFMD.

EV71 is a non-enveloped virus with a single-stranded, positive-sense genomic RNA of approximately 7.4 kb nucleotides. Protein 3A, a nonstructural viral protein of 87 amino acids in length, is required for enterovirus RNA replication ([@bib39]). 3A proteins play important role in enterovirus replication through the formation (with the 3CD protein) of replication organelles via remodeling of the internal cell membrane. Analyses of enterovirus 3A proteins have led to the identification of several cellular partners of this protein. The 3A proteins of PV and of the related coxsackievirus B3 (CV-B3) can interact with the cellular Golgi brefeldin A-resistant guanine nucleotide exchange factor 1 (GBF1). By interacting with GBF1, 3A inhibits the cellular secretory pathway. The membrane-anchored 3A protein modulates GBF1/Arf1 activity, resulting in the preferential recruitment of PI4KIIIβ to sites of viral RNA replication. PI4KIIIβ recruitment leads to the enrichment of virus-induced membranous organelles in PI4P, which has been shown to facilitate viral RNA replication. ([@bib3], [@bib2], [@bib12], [@bib15], [@bib16], [@bib40]). However, the function of 3A in the RNA replication of EV71 has been rarely reported. So, it is necessary to detect the mechanism of protein 3A and further explore the host factors involved in EV71 infection. Thus, to identify the host factors that could interact with 3A protein of EV71 may be a potential target for the therapy of HFMD.

The Na^+^/K^+^-ATPase is a transporter for Na^+^ and K^+^ ions across the plasma membranes and widely distributed in prokaryotic and eukaryotic cells. The 43-kDa ATP1B3, a β-subunit of ATPase, is localized to the q22\--\>23 region of Chromosome (Chr) 3 ([@bib4], [@bib25]). Previous studies have demonstrated that ATP1B3 can up-regulate lymphocyte activity and promote the production of IFN-γ, IL-2, IL-4, and IL-10([@bib7]) ([@bib9]). However, whether ATP1B3 can mediate the innate immune responses during EV71 infection is largely unknown. Moreover, Type I interferons (IFNs), namely IFNs-α/β, which lead to the induction of antiviral pathways within hours can be induced in virus-infected cells ([@bib42]). Type I IFNs have clinically been used for treatment of many viruses and tumors. Thus, identifying the host factors that can induce the production of type I IFNs is extremely important in controlling viral infection.

In this study we screened human ATP1B3 protein that could interact with EV71 3A protein using yeast two-hybrid system. We evaluated the effect of ATP1B3 on the inhibition of EV71 replication. Furthermore, we found that ATP1B3 can induce the production of type-I IFNs during EV71 infection. Overall, our work demonstrated that ATP1B3 might act as a potential therapeutic target in EV71 infection.

2. Materials and methods {#s0010}
========================

2.1. Yeast two-hybrid screening {#s0015}
-------------------------------

Full-length sequence of EV71 3A was inserted into the pGBKT7 vector for expression as a fusion protein with the Gal4 DNA-binding domain (Gal4-BD). This plasmid was used to transform the AH109 yeast strain (Clontech, Palo Alto, CA), and Gal4-BD fused 3A was used as bait in a mating strategy for the screening of human homogenization cDNA library. The homogenization cDNA library was inserted into the pGADT7 vector (Clontech, Palo Alto, CA) for expression as fusions with the Gal4 activation domain (Gal4-AD) and was maintained in the Y187 strain of yeast (Clontech, Palo Alto, CA). Transformed AH109 and Y187 yeast cells were mixed together for mating. Positive clones were selected on synthetic dropout medium lacking 4 nutrients (Leu/Trp/Ade/His). The blue colonies were kept, and the positive results were confirmed by repeating assays. cDNA plasmids isolated from positive colonies were introduced into Escherichia coli DH5α and sequenced. The sequences were analyzed with the BLAST program in NCBI.

2.2. Confocal microscopy experiments {#s0020}
------------------------------------

Confocal microscopy experiments were described previously ([@bib8]). In brief, the transfected cells were fixed with 3% paraformaldehyde (PFA), washed with PBS and permeabilized with 0.2% Triton X-100/PBS. Anti-flag and Anti-HA antibodies were used as the primary antibodies (1:1000 dilution), Alexa Fluor 488-conjugated Donkey anti-mouse IgG and Alexa Fluor 647-conjugated Donkey anti-rabbit IgG were used as secondary antibodies (1:500 dilution; Molecular Probes, abcam). DAPI dyes (Beyotime Institute of technology, China) was used for cell nucleus stains. The cells were examined and images were captured using 100x objectives with a confocal microscope (Leica SP8). The images were refined and figures were generated using Adobe Photoshop software (Adobe Systems, San Jose, CA).

2.3. Virus, cell lines, and construction of plasmids {#s0025}
----------------------------------------------------

The subgenotype C4 strain of EV71 virus (accession no: JX986738) was isolated from a throat swab with severe clinical symptoms at the Wuhan Medical Treatment Center (also Wuhan Infectious Diseases Hospital) ([@bib23]). To prepare virus stocks, viruses were propagated on 90% confluent monolayer cells in DMEM with 2% FBS as described previously ([@bib46]). HEK 293T and RD cells were grown in Dulbecco\'s minimal essential medium (DMEM; Lonza) supplemented with 10% fetal bovine serum, 100 μg/ml penicillin and 100 μg/ml streptomycin. All cells were cultured at 37 °C in a humidified atmosphere and 5% CO~2~. pCMV-flag-2B, pCMV-HA and pCMV-C1 vectors were obtained from Clontech (USA).

2.4. Knockdown of ATP1B3 {#s0030}
------------------------

The ATP1B3 small interfering RNA (siRNA) used in this study was designed at website <http://sidirect2.rnai.jp/>. The ATP1B3 siRNA oligonucleotide hairpins were generated with the DNA oligomers 5′-UUUUGGAACCUCAUCGUUGAG-3′, and

5′-CAACGAUGAGGUUCCAAAAUA-3′. A nonspecific siRNA

5′-UUCUCCGAACGUGUCACGUTT-3′ and 5′-ACGUGACACGUUC-GGAGAATT-3′ was used as negative control. All siRNAs were introduced into RD cells by the standard lipofection method using TurboFect Transfection Reagent (Theromo Scientific) following the manufacturer\'s protocol. All siRNAs were purchased from gema.

2.5. Real-time PCR {#s0035}
------------------

Total RNA was extracted from RD cells and the supernatants by using TRIzol reagent (TAKARA). Total RNA was reverse transcribed into cDNA using Moloney murine leukemia virus (MMLV) reverse transcriptase (promega) to detect transcript levels. SYBR green PCR master mix was used to conduct real-time qPCR to quantify the expression levels of each target gene. The real-time PCR was performed using a Lightcycler®480 instrument (Roche, Switzerland). The PCR was set up under the following thermal cycling conditions: 95 °C for 10 min, followed by 45 cycles of 95 °C for 15 s and 60 °C for 1 min. The expression levels were calculated using the comparative method for relative quantification after normalization to GAPDH gene expression. Primers used in RT-PCR were listed in [Table 1](#t0005){ref-type="table"} ([@bib22], [@bib23]).Table 1Primer sequences of mRNA analysis by real-time PCR.Table 1PrimerNucleotide sequence (5′ to 3′)GAPDH-FAAG GCT GTG GGC AAG GGGAPDH-RTGG AGG AGT GGG TGT CGATP1B3-FTGT CCT GAT GGA GCA CTTATP1B3-RCAA TCT ATC CTT GGC ACTIFN-α-FTTT CTC CTG CCT GAA GGA CAGIFN-α-RGCT CAT GAT TTC TGC TCT GAC AIFN-β-FTGG GAG GCT TGA ATA CTG CCTCAAIFN-β-RTCCTTGGCCTTCAGGTAATGCAGAEV71-FGCAGCCCAAAAGAACTTCACEV71-RATTTCAGCAGCTTGGAGTGC

2.6. Western blot analysis and co-immunoprecipitation {#s0040}
-----------------------------------------------------

Western blot and co-immunoprecipitation analyses were performed as previously described([@bib20]). Briefly, after cell treatment, cells were lysed using lysis buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 0.5% (vol/vol) Nonidet-P40, 1 mM EDTA, 30 mM NaF, 10% proteinase inhibitor mixture). Lysates were mixed and precipitated with antibodies or IgG and protein G--agarose beads (Roche, Basel, Switzerland) overnight at 4 °C. Beads were washed five times with lysis buffer containing 0.5 M NaCl before the bound proteins were eluted by boiling for 10 min in SDS sample lysis buffer. Protein samples were separated on polyacrylamide gels and transferred electrically to polyvinylidene fluoride membranes (Millipore, Billerica, USA). Immunoblots were visualized with an Enhance Chemiluminescent Detection Kit (Pierce, Rockford, USA) by Amersham Imager 600 instrument (GE Healthcare, Fairfield, USA).

2.7. Measurement of EV71 growth in ATP1B3 overpression RD cells after block of IFN α/β {#s0045}
--------------------------------------------------------------------------------------

After overpression AT1B3, RD cells were infected with EV71 at an MOI of 1. To neutralize interferon\'s activity, 2 μg of anti-human IFN-α1 (ab11408; Abcam) and anti-human IFN-β (ab6979; Abcam) were added to cell culture 3 h before EV71 infection. Twenty-four hours after EV71 infection, the viral contents were quantitated by RT-PCR using EV71 specific primers.

2.8. Statistical analysis {#s0050}
-------------------------

Statistical data are expressed as means±standard deviations (SD). Statistical analyses were performed using Prism 5 software (GraphPad, San Diego, CA). All other data were analyzed using Student\'s *t* test. Values of *p*\<0.05 were considered as statistically significant.

3. Results {#s0055}
==========

3.1. Human ATP1B3 interacts with EV71 3A protein in 293T cells {#s0060}
--------------------------------------------------------------

Yeast two-hybrid system found several positive clones containing the coding sequence of human ATP1B3 (GeneBank: BC011835.2), showing 100% nucleotide sequence identity. Data analysis in NCBI indicated that the 3A protein of EV71 could possibly interact with the N-terminal of the ATP1B3 protein. To further confirm the interaction between ATP1B3 and 3A protein, we performed immunofluorescent co-localization analysis by laser-scanning confocal microscopy. Results of confocal microscopic analysis of the subcellular localization revealed that the 3A fusion protein showed the same location with the ATP1B3 fusion protein on the membrane of 293T cells ( [Fig. 1](#f0005){ref-type="fig"}A). To further confirm the interaction between EV71 3A and ATP1B3, we first proformed exogenous Co-IP test. The RD cell line was transiently transfected with a Flag-tagged 3A expression vector and HA-tagged ATP1B3 expression vector. Following anti-Flag or anti-HA immunoprecipitation, the interaction between Flag-3A and HA-ATP1B3 was assessed by immunoblotting the precipitates for the presence of ATP1B3 or 3A. ATP1B3 or 3A protein was detected in the coimmunoprecipitation reaction from cell lysates that expressed both 3A and ATP1B3. To validate the interaction between the endogenous ATP1B3 and 3A in the context of EV71 infection, we performed immunoprecipitation experiment in RD cells infected with EV71 or mock infection using anti-3A or anti-ATP1B3. In both cases, 3A was revealed to interact with ATP1B3 ([Fig. 1](#f0005){ref-type="fig"}B and C).Fig. 1Immunoflorescent co-localization assay. (A) HEK293T cells transfected with flag-3A (green) and HA-ATP1)B3( (red) were subjected to immunofluorescent co-localization analysis and examined under a confocal microscope. DAPI was used to visualize the nuclei. Yellow in the merged image indicates colocalization of ATP1B3 and 3A. Scale bar represents 10 µm. (B) Exogenous interaction between EV71 3A and ATP1B3 in RD cells. Expression vectors for Flag-3A and pCMV-HA-ATP1B3 were transfected into RD cells, as indicated. Total cellular lysate was collected 48 h posttransfection. Coimmunoprecipitation using a IgG antibody as control. The bound proteins were subjected to Western blots using indicated antibodies. (C) Endogenous interaction between EV71 3A and ATP1B3. RD cells were infected with EV71 or mock infected for 24 h, Co-IP analysis was performed with anti-3A antibody or control anti-ATP1B3 antibody by Western blot.Fig. 1

3.2. The relationship between 3A protein levels and endogenous ATP1B3 expression in RD cells {#s0065}
--------------------------------------------------------------------------------------------

In order to better understand the function of ATP1B3 in EV71 infection, we detected the expression levels of ATP1B3 after transfection plasmid DNA encoding enhanced green fluorescent protein (EGFP) with and without 3A into RD cells (EV71-susceptible cells). The fluorescence of EGFP was used to detect the transfection efficiency and expression levels of 3A protein ( [Fig. 2](#f0010){ref-type="fig"}A). We observed that the mRNA expression levels of ATP1B3 had no significant difference after the transfection of various doses of plasmid EGFP-3A ([Fig. 2](#f0010){ref-type="fig"}B). The results showed that EV71 3A protein in RD cells cannot promote the expression of endogenous ATP1B3.Fig. 2Expression of ATP1B3 in RD cells after transfect different doses of plasmid EGFP-3A**.** RD cells were transfected different doses of EGFP-3A for 24 h and analyzed by real-time PCR. (A) EGFP vector ([Fig. 2](#f0010){ref-type="fig"}A upper left), 0.5 μg EGFP-3A ([Fig. 2](#f0010){ref-type="fig"}A upper right), 1 μg EGFP-3A ([Fig. 2](#f0010){ref-type="fig"}A lower left), 1.5 μg EGFP-3A ([Fig. 2](#f0010){ref-type="fig"}A lower right) were transfected into RD cells respectively. In the photographs, green fluorescent represents different 3A fusion protein expression in RD cells. (B) No significant difference in ATP1B3 expression level was observed after transfection of different does EGFP-3A vector in RD cells. (*P*\>0.05).Fig. 2

3.3. The dynamic expression of ATP1B3 in RD cells during EV71 infection {#s0070}
-----------------------------------------------------------------------

Next we assessed the expression of ATP1B3 during EV71 infection. The RD cells were infected with EV71 at a MOI of 1 for 0, 6, 12, 24, 48 and 72 h respectively. During the infection of EV71, we found that the mRNA expression levels of ATP1B3 were elevated continuously in RD cells and had a significant difference compared with that in the uninfected cells. Consistent with the results of mRNA levels, western blot revealed that protein levels of ATP1B3 were also significantly elevated after EV71 infection ( [Fig. 3](#f0015){ref-type="fig"}A). On the other hand, we infected the RD cells at different MOIs of EV71 for 72 h and detected ATP1B3 expression. We observed that both the mRNA and protein levels of ATP1B3 in RD cells were positively correlated with the infection doses of EV71 ([Fig. 3](#f0015){ref-type="fig"}B). Thus, ATP1B3 expression levels were elevated along with the increasing of infection time and doses of EV71.Fig. 3Effect of EV71 on the expression of ATP1B3 in RD cells**.** (A) RD cells were infected with EV71 (MOI=1) for 0, 6, 12, 24, 48 and 72 h. ATP1B3 RNA levels were quantified by real-time PCR (upper panel) and protein levels were detected by western blot (lower panel). (B) RD cells were infected with different doses of EV71 for 72 h. ATP1B3 RNA levels were quantified by real-time RT-PCR (upper panel) and protein levels of ATP1B3 and were detected by western blot (lower panel). Experiments were performed three times with similar results. Data represent means±SD of at least three independent experiments.Fig.3

3.4. ATP1B3 inhibits the replication of EV71 in RD cells {#s0075}
--------------------------------------------------------

Since EV71 infection could induce the production of ATP1B3, we investigated whether ATP1B3 affected the replication cycle of EV71. ATP1B3 siRNA and its control siRNA were transfected into RD cells to knockdown ATP1B3 expression and negative control, respectively ( [Fig. 4](#f0020){ref-type="fig"}A). The presence of EV71 in the cell cultures was determined by quantitative real-time PCR using EV71 specific primers. The expression of EV71 3C protein was analyzed by western blot to represent the replication of EV71 in RD cells. Our results showed that knockdown ATP1B3 could increase both the mRNA and 3C protein levels of EV71 ([Fig. 4](#f0020){ref-type="fig"}B). Furthermore, pCMV-ATP1B3 vector was transfected into RD cells and induced about a three-fold rise of ATP1B3 expression compared with the negative control group ([Fig. 4](#f0020){ref-type="fig"}C). We observed that overexpression of ATP1B3 could inhibit the expression of both the mRNA and 3C protein levels of EV71 ([Fig. 4](#f0020){ref-type="fig"}D). Our results showed that ATP1B3 could inhibit the replication of EV71.Fig. 4The relationship between ATP1B3 expression and the replication of EV71**.** (A) ATP1B3 in mRNA and protein levels were shown after knockdown ATP1B3. (B) Total EV71 RNA and protein levels after knockdown ATP1B3 were determined by RT-PCR and western blot with EV71 specific primers and anti-3C antibody. (C) ATP1B3 in mRNA and protein levels were shown after overexpress ATP1B3. (D) Total EV71 RNA and protein levels after overexpress ATP1B3 were determined by RT-PCR and western blot with EV71 specific primers and anti-3C antibody. The bar graphs showed as the means±SD of at least three independent experiments. (\**P*\<0.05,\*\**P*\<0.01).Fig.4

3.5. EV71 relpication is associated with type I IFNs {#s0080}
----------------------------------------------------

The type I IFNs act as the key effectors in the innate immune response against RNA virus infection ([@bib18], [@bib31]). To explore the mechanism of the ATP1B3-mediated anti-EV71 response, we examined the relationship between ATP1B3 expression levels and Type I IFNs production. The levels of IFNs-α/β mRNA in RD cells were detected by quantitative real-time PCR. The intracellular levels of IFNs-α/β mRNA in RD cells were significantly decreased after knockdown of ATP1B3 expression using ATP1B3 siRNA ( [Fig. 5](#f0025){ref-type="fig"}A). On the contrary, IFNs-α/β mRNA levels were significantly increased when ATP1B3 was overexpressed compared with control vector ([Fig. 5](#f0025){ref-type="fig"}B). This showed that ATP1B3 promoted the production of type I IFNs. Since EV71 replication was reduced in ATP1B3 overpression cells, it would be intriguing to determine if such reduction is associated with the elevated type I interferon expression. We infected ATP1B3 overpression cells or vector controls with EV71 at an MOI of 1, cultured cells with anti-human interferon-α1/β antibodies or isotype control IgG, and examined the viral replication using RT-PCR assay. We found that ATP1B3 overpression-induced reduction of viral growth was increased by treatment with antiinterferon-α1/β antibodies but not by its isotype control IgG ([Fig. 5](#f0025){ref-type="fig"}C), indicating that neutralization of type I interferon in the cell culture by anti-interferon-α1/β antibodies restored EV71 growth in ATP1B3 overpression cells.Fig. 5EV71 relpication is associated with type I IFNs. RD cells were transfected with the indicated si-RNAs or plasmids 24 h later. Post-transfection, cells were infected with EV71 (MOI=1). RD Cells were harvested after another 24 h post-infection. (A) After knockdown ATP1B3, IFN-α RNA and IFN-β RNA levels were decreased about 65% and 70%. (B) After overpression ATP1B3, IFN-α RNA and IFN-β RNA levels were both upregulated about 4.5 folds. IFN-α RNA and IFN-β RNA levels were determined by real-time PCR with specific primers. Experiments were performed three times with similar results. All graphs represent means±SD. (\**P*\<0.05,\*\**P*\<0.01). (C)To neutralize interferons, anti-human IFN-α and anti-human IFN-β monoclonal antibodies or isotype control IgG were added to cell cultures 3 h before EV71 infection. Twenty-four hours after EV71 infection, the cell culture samples were freeze-thawed three times. The viral contents were quantitated by RT-PCR using EV71 specific primers. Data are presented as means±SD, n=3. (\* *P*\<0.05).Fig.5

3.6. Discussion and conclusions {#s0085}
-------------------------------

In recent years, EV71 epidemics have occurred in various provinces in China and caused an increasing proportion of severe complications and deaths in children. According to Chinese center for disease control and prevention, from January 2015 to December 2015, 2.01 million cases of HFMD had been reported in mainland China, of which 124 were dead ([@bib29]). More than 80% of the pathogens isolated from patients died from HFMD were identified as EV71. Lots of research on developing antiviral drugs and vaccines were largely unsuccessful. Intravenous immunoglobulin, ribavirin and pleconaril have been demonstrated the antiviral activity in vitro and in vivo, but these drugs cannot inhibit the cytopathic effect induced by EV71 ([@bib47]). Previous studies have shown that 3A protein of enterovirus plays a critical role in viral RNA replication and is a potential target for antiviral therapy ([@bib11], [@bib14], [@bib32]). Itraconazole and enviroxime can target viral protein 3A and/or 3AB and suppress replication of EV71 in vitro ([@bib1], [@bib14]). So we conducted a yeast two-hybrid screening procedure to screen human proteins that could interact with EV71 3A protein. Moreover, we confirmed human protein ATP1B3 is the target of EV71 3A protein. Thus it is important to explore the function of human ATP1B3 during EV71 infection.

Previous studies have shown that some subunits of Na^+^/K^+^-ATPase can interact with various viral proteins and affect the replication of viruses. It has been demonstrated that ATP1B1 subunit interacts with HCMV UL136 protein, M2 proteins of influenza A and B viruses and inhibit the virus replication ([@bib10], [@bib28]). ATP1A1 has also been reported to inhibit entry of coronavirus into host cells by regulating the Src signaling pathway ([@bib5]). ATP1B3 is expressed separately from the α subunit, and plays a role in regulation of the immune response ([@bib9]). A recent published study suggested that ATP1B3 can modulate the restriction of HIV-1 production and NF-κB activation in a BST-2 dependent manner ([@bib30]). All of these researches suggest that ATPase subunits play an important role in innate immunity against virus infection. However, the function of ATP1B3 in EV71 infection has been largely unknown. In this manuscript, we found EV71 infection can induce increases in ATP1B3 levels. Further studies demonstrated that ATP1B3 can inhibit EV71 replication along with the induction of IFN-α/IFN-β. Therefore ATP1B3 play an important role in antiviral immune response. Type I IFNs serve as key factors in the innate and adaptive immune responses against virus infection. IFNs have been demonstrated effective in many viruses such as influenza A virus ([@bib38]), hepatitis C virus ([@bib27]), coxsackievirus type A16 infection ([@bib44]). Some studies have demonstrated that type I IFNs represent an essential innate defense mechanism for controlling EV71 infection both in vitro and in vivo ([@bib17], [@bib21], [@bib22]). Previous studies have shown that EV71 infection can induce IFN-β production which is dependent on the infectious dose, but the interferon is not cell type specific ([@bib24]). It has also demonstrated that EV71 infection promoted the expression of son of sevenless and increased the secretion of IL-1α, IL-2, IL-6, IL-12, TNF-α, IFN-β and IFN-γ ([@bib36]). In our current study, we found that the levels of type I IFNs (IFN-α/IFN-β) were negatively associated with EV71 replication. Previous studies have shown that IFN-mediated resistance to viral infection in vitro is dependent on the inhibition of viral replication ([@bib34]). In our manuscript we found overpression ATP1B3 inhibited EV71 growth, and this inhibition could be effectively abolished by type I IFNs antibodies in the cell culture. Our data suggests that ATP1B3 inhibits the replication of EV71by inducing the production of type I IFNs.

To our knowledge, this is the first time to illustrate the function of ATP1B3 in innate immunity and the life cycle of EV71 at molecular level. ATP1B3 can act as a potential new therapeutic target for EV71 infection and the related disorders. This finding will broaden our understanding of host defense mechanism and the pathogenesis of EV71 infection.
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